尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Zocca Mai-Britt, 首席执行官. Officer active across 1 company, notably IO Biotech, Inc.. Aggregated, 3 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. History available since 9 August 2023. The latest transaction was filed on 23 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Mai-Britt Zocca is Chief Executive Officer of IO Biotech, Inc. She leads the company with a focus on innovation and the development of new treatments. Her leadership is essential in achieving IO Biotech's objectives.